Consolidated Statement Of Cash Flows (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 25, 2010	Dec. 26, 2009
Operating Activities
Net income	$ 6,462	$ 6,338	$ 5,979
Depreciation and amortization	2,737	2,327	1,635
Stock-based compensation expense	326	299	227
Restructuring and impairment charges	383		36
Cash payments for restructuring charges	(31)	(31)	(196)
Merger and integration costs	329	808	50
Cash payments for merger and integration costs	(377)	(385)	(49)
Gain on previously held equity interests in PBG and PAS		(958)
Asset write-off		145
Non-cash foreign exchange loss related to Venezuela devaluation		120
Excess tax benefits from share-based payment arrangements	(70)	(107)	(42)
Pension and retiree medical plan contributions	(349)	(1,734)	(1,299)
Pension and retiree medical plan expenses	571	453	423
Bottling equity income, net of dividends		42	(235)
Deferred income taxes and other tax charges and credits	495	500	284
Change in accounts and notes receivable	(666)	(268)	188
Change in inventories	(331)	276	17
Change in prepaid expenses and other current assets	(27)	144	(127)
Change in accounts payable and other current liabilities	520	488	(133)
Change in income taxes payable	(340)	123	319
Other, net	(688)	(132)	(281)
Net Cash Provided by Operating Activities	8,944	8,448	6,796
Investing Activities
Capital spending	(3,339)	(3,253)	(2,128)
Sales of property, plant and equipment	84	81	58
Acquisitions of PBG and PAS, net of cash and cash equivalents acquired		(2,833)
Acquisition of manufacturing and distribution rights from DPSG		(900)
Investment in WBD	(164)	(463)
Other acquisitions and investments in noncontrolled affiliates	(601)	(83)	(500)
Divestitures	780	12	99
Cash restricted for pending acquisitions			15
Short-term investments, by original maturity
More than three months - purchases		(12)	(29)
More than three months - maturities	21	29	71
Other investing, net	(16)	(17)
Net Cash Used for Investing Activities	(5,618)	(7,668)	(2,401)
Financing Activities
Proceeds from issuances of long-term debt	3,000	6,451	1,057
Payments of long-term debt	(1,596)	(59)	(226)
Debt repurchase	(771)	(500)
Short-term borrowings, by original maturity
More than three months - proceeds	523	227	26
More than three months - payments	(559)	(96)	(81)
Three months or less, net	339	2,351	(963)
Cash dividends paid	(3,157)	(2,978)	(2,732)
Share repurchases - common	(2,489)	(4,978)
Share repurchases - preferred	(7)	(5)	(7)
Proceeds from exercises of stock options	945	1,038	413
Excess tax benefits from share-based payment arrangements	70	107	42
Acquisition of noncontrolling interests	(1,406)	(159)
Other financing	(27)	(13)	(26)
Net Cash (Used for)/Provided by Financing Activities	(5,135)	1,386	(2,497)
Effect of exchange rate changes on cash and cash equivalents	(67)	(166)	(19)
Net (Decrease)/Increase in Cash and Cash Equivalents	(1,876)	2,000	1,879
Cash and Cash Equivalents, Beginning of Year	5,943	3,943	2,064
Cash and Cash Equivalents, End of Year	4,067	5,943	3,943
Non-cash activity:
Issuance of common stock and equity awards in connection with our acquisitions of PBG and PAS, as reflected in investing and financing activities		4,451
WBD [Member]
Investing Activities
Acquisition of WBD, net of cash and cash equivalents acquired	(2,428)
Three Months Or Less Maturity [Member]
Short-term investments, by original maturity
Three months or less, net	$ 45	$ (229)	$ 13